34 reports

  • 7. Global Cystic Fibrosis Pipeline Product Analysis - By Company & Phase of Development
  • 10.Global Cystic Fibrosis Market - Growth Drivers

Novartis Pharmaceuticals Corporation Novartis Pharmaceuticals Corporation Savara Pharmaceuticals CURx Pharma Anti-Inflammatory Anti-Infective Gallium (IV) ##.

  • Cystic Fibrosis
  • Pathology
  • Pharmaceutical
  • Respiratory Treatment
  • Genzyme Corporation
  • Sanofi
  • Increase in R&D

Develops, manufactures, and markets pharmaceuticals worldwide.

  • Pharmaceutical
  • Vaccine
  • Amgen Inc.
  • Genzyme Corporation
  • Novo Nordisk Group
  • Pipeline Assessment
  • SANOFI'S MULTIPLE SCLEROSIS PORTFOLIO ASSESSMENT, 2015

ONO PHARMACEUTICAL HAS SINCE DISCONTINUED THE PRODUCT.

  • Pharmaceutical
  • World
  • Demand
  • Forecast
  • Genzyme Corporation
  • MARKET PARTICIPANTS
  • COMPETITIVE SCENARIO

Actelion Pharmaceuticals also supplies Zavesca to Teva Pharmaceutical Industries.

  • Pharmaceutical
  • United States
  • World
  • Forecast
  • Genzyme Corporation

IN ADDITION, THE COMPANY ONCE AGAIN RECEIVED THE HIGHEST MARK OF " EXCELLENT" IN THE 2016 PROFARMA PLAN, AN INITIATIVE OF THE SPANISH GOVERNMENT TO INCREASE COMPETITIVENESS OF THE NATIONAL PHARMACEUTICAL INDUSTRY.

  • Hospital
  • Medical Supply
  • Pharmaceutical
  • Wound Care
  • Genzyme Corporation

GLOBALDATA ADHERES TO THE CODES OF PRACTICE OF THE EUROPEAN PHARMACEUTICAL MARKETING RESEARCH ASSOCIATION THE OBJECTIVE OF UPDATING GLOBALDATA' S COVERAGE IS TO ENSURE THAT IT REPRESENTS THE MOST UP-TO-DATE VISION OF THE INDUSTRY POSSIBLE.

  • Hospital
  • Oxygen Device
  • Pharmaceutical
  • Wound Care
  • Genzyme Corporation
  • 3.1 Key Trends and Developments

Figure ##. ##: The US Pharmaceutical Monthly Sales Growth (January 2013- The pharmaceutical market is broadly divided into two categories: traditional pharmaceuticals and specialty pharmaceuticals.

  • Pharmaceutical
  • Amgen Inc.
  • Biogen Idec Inc.
  • Eli Lilly & Co.
  • Genzyme Corporation
  • Market challenges

In addition, these countries are also working on providing incentives such as reimbursements to pharmaceutical manufacturers to encourage research in this area.

  • Pharmaceutical
  • Europe
  • United States
  • Market Size
  • Genzyme Corporation
  • 03.2 Product Offerings
  • 01. Executive Summary

Actelion Pharmaceuticals: Product Portfolio Actelion Pharmaceuticals Actelion Pharmaceuticals reported sales worth US$##. ## million in FY2013 for Zavesca.

  • Pharmaceutical
  • World
  • Forecast
  • Market Segment
  • Genzyme Corporation
  • Replagal SWOT Analysis, 2015
  • Fabrazyme SWOT Analysis, 2015

Pharma Japan Web (2015).

  • Neurological Disorder
  • Pharmaceutical
  • Therapy
  • Amicus Therapeutics
  • Genzyme Corporation

MOBILE Mobile advertising has primarily driven social media ad spend by pharmaceutical & healthcare brands, accounting for ##%, in 2015.

  • Advertising
  • Computer
  • Pharmaceutical
  • Web 2.0
  • Tencent Holdings Ltd

FIGURE ##: CHINA RETAIL BRANDS' ONLINE ADVERTISING SPEND - SPLIT BY MOBILE AND DESKTOP (US$ MILLION), 2015 VS. 2020 ##. ## Pharmaceutical & Healthcare Online Ad Spend Being among the few countries that allow direct to consumer marketing of pharmaceutical products, digital ad

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • 18.2 BIOMARIN PHARMACEUTICAL
  • 17.2 MARKET SHARE ANALYSIS 2014
  • Pharmaceutical
  • Therapy
  • World
  • Forecast
  • Genzyme Corporation
  • Vendor landscape
  • Scope of the report

The company develops and commercializes pharmaceutical products.

  • Pharmaceutical
  • Therapy
  • United States
  • Amicus Therapeutics
  • Genzyme Corporation

MOBILE Mobile advertising has primarily driven social media ad spend by pharmaceutical & healthcare brands, accounting for ##%, in 2014.

  • Advertising
  • Marketing
  • Pharmaceutical
  • Web 2.0
  • Tencent Holdings Ltd
  • SANOFI'S MULTIPLE SCLEROSIS PORTFOLIO ASSESSMENT, 2015

Ono Pharmaceutical has since discontinued the product.

  • Pharmaceutical
  • Therapy
  • Biogen Idec Inc.
  • Genzyme Corporation
  • Novartis AG
  • Pipeline Assessment
  • LEADING DISEASE-MODIFYING DRUGS FOR THE TREATMENT OF MS, 2015

MONTVILLE, NJ: BAYER HEALTHCARE PHARMACEUTICALS; 1993.

  • Pharmaceutical
  • Therapy
  • World
  • Demand
  • Genzyme Corporation
  • Pipeline Assessment
  • LEADING DISEASE-MODIFYING DRUGS FOR THE TREATMENT OF MS, 2015

MONTVILLE, NJ: BAYER HEALTHCARE PHARMACEUTICALS; 1993.

  • Pharmaceutical
  • Therapy
  • World
  • Demand
  • Genzyme Corporation
  • Pipeline Assessment
  • LEADING DISEASE-MODIFYING DRUGS FOR THE TREATMENT OF MS, 2015

MONTVILLE, NJ: BAYER HEALTHCARE PHARMACEUTICALS; 1993.

  • Pharmaceutical
  • Therapy
  • World
  • Demand
  • Genzyme Corporation
  • Pipeline Assessment
  • LEADING DISEASE-MODIFYING DRUGS FOR THE TREATMENT OF MS, 2015

MONTVILLE, NJ: BAYER HEALTHCARE PHARMACEUTICALS; 1993.

  • Pharmaceutical
  • Therapy
  • World
  • Demand
  • Genzyme Corporation
  • Pipeline Assessment
  • LEADING DISEASE-MODIFYING DRUGS FOR THE TREATMENT OF MS, 2015

MONTVILLE, NJ: BAYER HEALTHCARE PHARMACEUTICALS; 1993.

  • Pharmaceutical
  • Therapy
  • World
  • Demand
  • Genzyme Corporation
  • GLOBAL SALES OF BRANDED PRODUCTS FOR DYSLIPIDEMIA BY COMPANY, 2013-2023
  • KEY COMPANIES IN THE DYSLIPIDEMIA MARKET IN THE 8MM, 2014

AEGERION PHARMACEUTICALS, INC. (2014).

  • Cardiovascular Disease
  • Cholesterol
  • Lipid Modifying Drug
  • Pharmaceutical
  • Genzyme Corporation
  • GAUCHER DISEASE: KEY METRICS IN THE SEVEN MAJOR PHARMACEUTICAL MARKETS, 2014-2024
  • Executive Summary
  • Epidemiology
  • Health Care Provider
  • Pharmaceutical
  • Therapy
  • Genzyme Corporation

FIGURE ##: CHINA PHARMACEUTICAL & HEALTHCARE BRANDS' ONLINE ADVERTISING SPEND (US$ MILLION), 2010-2019 ##. ##. ## SNAPSHOT, 2010-2019 FIGURE ##: CHINA PHARMACEUTICAL & HEALTHCARE BRANDS' ONLINE ADVERTISING SPEND - BREAKDOWN BY MARKETING OBJECTIVE (%), 2014VS. 2019 Bran

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2017

JCR PHARMACEUTICALS CO LTD Lixte Biotechnology Holdings Inc (Lixte) is a clinical stage pharmaceutical company, which focuses on the discovery of novel drugs for the treatment of cancer and non-malignant diseases.

  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Genzyme Corporation
  • Genzyme Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017
  • Genzyme Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017
  • Pharmaceutical
  • Therapy
  • United States
  • M&A
  • Genzyme Corporation
  • Products under Development by Companies, H2 2016
  • Gaucher Disease Type III - Therapeutics under Development by Companies

Belrose Pharma is headquartered in Princeton, New Jersey, the US.

  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Genzyme Corporation
  • Target
  • CORPORATE VENTURING - DEAL REPORTS

Following the acquisition, the pharmaceutical intermediates business will be renamed as Corden Pharma Switzerland, LLC and will operate as part of ICIG' s pharmaceutical business within the Corden Pharma platform.

  • Pharmaceutical
  • United States
  • Company
  • M&A
  • Genzyme Corporation
  • Pompe Disease - Dormant Projects
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES

Co Ltd, is a pharmaceutical company that provides medical solutions for human health.

  • Neurological Disorder
  • Pharmaceutical
  • United States
  • Product Initiative
  • Genzyme Corporation
  • Untitled
  • Clinical Trial Profile Snapshots

BioMarin Pharmaceutical Inc.

  • Neurological Disorder
  • Pharmaceutical
  • World
  • Product Initiative
  • Genzyme Corporation